Kinnari Patel, President, Head of R&D and COO at Rocket Pharmaceuticals, holds 503.00K shares in Rocket Pharmaceuticals (Ticker: RCKT). Most recently, Kinnari Patel Sold $4,588 shares of Rocket Pharmaceuticals on Nov 25, 2024 for an estimated value of 59.87K.
What is the percentage of profitable transactions made by Kinnari Patel?
The percentage of profitable transactions made by Kinnari Patel is 67%.
What is the average return per transaction made by Kinnari Patel?
The average return per transaction made by Kinnari Patel is 74.20%.
What stocks does Kinnari Patel hold?
Kinnari Patel holds: RCKT stocks.
What was Kinnari Patel’s latest transaction?
Kinnari Patel latest transaction was an Informative Sell of $59.87K.
What was Kinnari Patel's most profitable transaction?
Kinnari Patel’s most profitable transaction was an Informative Buy of RCKT stock on March 19, 2020. The return on the trade was 323.80%.
What is Kinnari Patel's role in Rocket Pharmaceuticals?
Kinnari Patel's role in Rocket Pharmaceuticals is President, Head of R&D and COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.